Analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Wednesday. The firm set a “buy” rating on the stock.
Mannatech Price Performance
Shares of NASDAQ MTEX opened at $7.50 on Wednesday. The business’s fifty day simple moving average is $7.44 and its 200-day simple moving average is $7.63. Mannatech has a 12-month low of $6.75 and a 12-month high of $10.51. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. The company had revenue of $27.74 million during the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.
Insiders Place Their Bets
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Recommended Stories
- Five stocks we like better than Mannatech
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What Investors Need to Know About Upcoming IPOs
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.